New developments in tissue engineering of vascular prosthetic grafts

Vasa - Journal of Vascular Diseases

Volumn 38, Issue 2, 2009, Pages 99-122

  Aper, T ^a   Haverich, A ^a   Teebken, Omke ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Endothelial cell seeding; Small calibre vascular graft; Tissue engineering; Vascular graft

Indexed keywords

BIOMATERIAL; COLLAGEN; DACRON; POLITEF; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; POLYURETHAN; RAPAMYCIN; SCLEROPROTEIN; TISSUE SCAFFOLD;

ALLOGRAFT; ANEURYSM; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; AUTOGRAFT; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOMECHANICS; BIOREACTOR; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL PROSTHESIS; BONE MARROW TRANSPLANTATION; CELL ADHESION; COCULTURE; CONGENITAL HEART DISEASE; CORONARY ARTERY BYPASS SURGERY; CRYOPRESERVATION; DONOR; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMOROPOPLITEAL BYPASS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MATERIALS TESTING; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PROSTHESIS INFECTION; PROSTHESIS MATERIAL; REVIEW; SMALL INTESTINE MUCOSA; STEM CELL TRANSPLANTATION; STENT; TISSUE ENGINEERING; TISSUE PRESERVATION; VASCULAR PATENCY; VEIN BYPASS; VEIN GRAFT; VEIN VALVE; XENOGRAFT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; METHODOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSTHESIS; TISSUE REGENERATION; TISSUE TRANSPLANTATION; TRANSPLANTATION;

ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; CORONARY ARTERY BYPASS; CORONARY STENOSIS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; GUIDED TISSUE REGENERATION; HUMANS; POLYMERS; PROSTHESIS DESIGN; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TISSUE TRANSPLANTATION;

EID: 73149118235     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.38.2.99     Document Type: Review

References (237)

1. Abbott WM, Megerman J, Hasson JE, L'Italien G, Warnock DF. Effect of compliance mismatch on vascular graft patency. J Vasc Surg 1987; 5: 376-82.
2. Alexander J, Gutierrez C, Katz S. Non-greater saphenous vein grafting for infrageniculate bypass. Am Surg 2002; 68: 611-4.
3. Allen J, Khan S, Serrano MC, Ameer G. Characterization of Porcine Circulating Progenitor Cells: Toward a Functional Endothelium. Tissue Eng 2008.
4. Aper T, Schmidt A, Duchrow M, Bruch HP. Autologous blood vessels engineered from peripheral blood sample. Eur J Vasc Endovasc Surg 2007; 33: 33-9.
5. Aper T, Teebken OE, Steinhoff G, Haverich A. Use of a fibrin preparation in the engineering of a vascular graft model. Eur J Vasc Endovasc Surg 2004; 28: 296-302.
6. Armstrong PA, Bandyk DF, Wilson JS, Shames ML, Johnson BL, Back MR. Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy. J Vasc Surg 2004; 40: 724-30; discussion 30-1.
7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
8. Ascer E, Veith FJ, Morin L, Lesser ML, Gupta SK, Samson RH, et al. Components of outflow resistance and their correlation with graft patency in lower extremity arterial reconstructions. J Vasc Surg 1984; 1: 817-28.
9. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006; 355: 1222-32.
10. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-17.
11. Ballyk PD, Walsh C, Butany J, Ojha M. Compliance mismatch may promote graft-artery intimal hyperplasia by altering suture-line stresses. J Biomech 1998; 31: 229-37.
12. Batt M, Magne JL, Alric P, Muzj A, Ruotolo C, Ljungstrom KG, et al. In situ revascularization with silver-coated polyester grafts to treat aortic infection: early and midterm results. J Vasc Surg 2003; 38: 983-9.
13. Beard JD, Benveniste GL, Miller JH, Baird RN, Horrocks M. Haemodynamics of the interposition vein cuff. Br J Surg 1986; 73: 823-5.
14. Belkin M, Raftery KB, Mackey WC, McLaughlin RL, Umphrey SE, Kunkemueller A, et al. A prospective study of the determinants of vein graft flow velocity: implications for graft surveillance. J Vasc Surg 1994; 19: 259-65; 65-7.
15. Bellon JM, Bujan J, Honduvilla NG, Hernando A, Navlet J. Endothelial cell seeding of polytetrafluoroethylene vascular prostheses coated with a fibroblastic matrix. Ann Vasc Surg 1993; 7: 549-55.
16. Bellon JM, Bujan J, Honduvilla NG, Hernando A, Navlet J. Behavior of cryopreserved endothelial cells in different phases: their application in the seeding of vascular prostheses. Ann Vasc Surg 1995; 9: 266-73.
17. Berglund JD, Mohseni MM, Nerem RM, Sambanis A. A biological hybrid model for collagen-based tissue engineered vascular constructs. Biomaterials 2003; 24: 1241-54.
18. Bhattacharya V, McSweeney PA, Shi Q, Bruno B, Ishida A, Nash R, et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 2000; 95: 581-5.
19. Biasi GM, Mingazzini P, Baronio L, Sampaolo A. Processed bovine pericardium as patch angioplasty for carotid endarterectomy: a preliminary report. Cardiovasc Surg 1996; 4: 591-5.
20. Bleiziffer O, Eriksson E, Yao F, Horch RE, Kneser U. Gene transfer strategies in tissue engineering. J Cell Mol Med 2007; 11: 206-23.
21. Bohmig HJ, Zeidler G, Schwierz T, Loy E. [20 years orthograde venous bypass for infrainguinal arterial reconstruction]. Chirurg 1995; 66: 120-6.
22. Boyer M, Townsend LE, Vogel LM, Falk J, Reitz-Vick D, Trevor KT, et al. Isolation of endothelial cells and their progenitor cells from human peripheral blood. J Vasc Surg 2000; 31: 181-9.
23. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003; 108: 2212-8.
24. Brochado-Neto FC, Albers M, Pereira CA, Gonzalez J, Cinelli M, Jr. Prospective comparison of arm veins and greater saphenous veins as infrageniculate bypass grafts. Eur J Vasc Endovasc Surg 2001; 22: 146-51.
25. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 2004; 109: 2518-23.
26. Campbell CD, Brooks DH, Webster MW, Bahnson HT. The use of expanded microporous polytetrafluoroethylene for limb salvage: a preliminary report. Surgery 1976; 79: 485-91.
27. Campbell CD, Goldfarb D, Detton DD, Roe R, Goldsmith K, Diethrich EB. Expanded polytetrafluoro-ethylene as a small artery substitute. Trans Am Soc Artif Intern Organs 1974; 20A: 86-90.
28. Campbell JB, Glover JL, Herring B. The influence of endothelial seeding and platelet inhibition on the patency of ePTFE grafts used to replace small arteries-an experimental study. Eur J Vasc Surg 1988; 2: 365-70.
29. Carrel A. The surgery of blood vessels. Bull Johns Hopk Hosp 1906; 19: 18-27.
30. Chang HJ, Park JS, Kim MH, Hong MH, Kim KM, Kim SM, et al. Extracellular signal-regulated kinases and AP-1 mediate the up-regulation of vascular endothelial growth factor by PDGF in human vascular smooth muscle cells. Int J Oncol 2006; 28: 135-41.
31. Christenson EM, Dadsetan M, Wiggins M, Anderson JM, Hiltner A. Poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo studies. J Biomed Mater Res A 2004; 69: 407-16.
32. Christenson JT, Eklof B. Sparks mandril, velour Dacron and autogenous saphenous vein grafts in femoropopliteal bypass. Br J Surg 1979; 66: 514-7.
33. Chue WL, Campbell GR, Caplice N, Muhammed A, Berry CL, Thomas AC, et al. Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts. J Vasc Surg 2004; 39: 859-67.
34. Coleman JE, McEnroe CS, Gelfand JA, Connolly RJ, Callow AD. Complement activation by vascular sutures both alone and in combination with synthetic vascular prostheses. Eur J Vasc Surg 1991; 5: 287-90.
35. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994; 28: 655-66.
36. Dahl SL, Koh J, Prabhakar V, Niklason LE. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 2003; 12: 659-66.
37. Daly CD, Campbell GR, Walker PJ, Campbell JH. In vivo engineering of blood vessels. Front Biosci 2004; 9: 1915-24.
38. Dardik HD, Ibrahim IM, Sprayregen S, Dardik II. Clinical experience with modifi ed human umbilical cord vein for arterial bypass. Surgery 1976; 79: 618-24.
39. Davidovic L, Vasic D, Maksimovic R, Kostic D, Markovic D, Markovic M. Aortobifemoral grafting: factors influencing long-term results. Vascular 2004; 12: 171-8.
40. Davies MG, Hagen PO. The vascular endothelium. A new horizon. Ann Surg 1993; 218: 593-609.
41. de Borst GJ, Teijink JA, Patterson M, Quijano TC, Moll FL. A percutaneous approach to deep venous valve insuffi ciency with a new self-expanding venous frame valve. J Endovasc Ther 2003; 10: 341-9.
42. De Vriese AS, Billiet J, Van Droogenbroeck J, Ghekiere J, De Letter JA. Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans. J Intern Med 2008; 263: 395-403.
43. DeBakey ME, Creech O, Jr., Cooley DA. Occlusive disease of the aorta and its treatment by resection and homograft replacement. Ann Surg 1954; 140: 290-310.
44. Denner J, Specke V, Karlas A, Chodnevskaja I, Meyer T, Moskalenko V, et al. No transmission of porcine endogenous retroviruses (PERVs) in a longterm pig to rat xenotransplantation model and no infection of immunosuppressed rats. Ann Transplant 2008; 13: 20-31.
45. Desgranges P, Beaujan F, Brunet S, Cavillon A, Qvarfordt P, Melliere D, et al. Cryopreserved arterial allografts used for the treatment of infected vascular grafts. Ann Vasc Surg 1998; 12: 583-8.
46. Deutsch M, Meinhart J, Fischlein T, Preiss P, Zilla P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 1999; 126: 847-55.
47. Divya P, Sreerekha PR, Krishnan LK. Growth factors upregulate deposition and remodeling of ECM by endothelial cells cultured for tissue-engineering applications. Biomol Eng 2007; 24: 593-602.
48. Dixit P, Hern-Anderson D, Ranieri J, Schmidt CE. Vascular graft endothelialization: comparative analysis of canine and human endothelial cell migration on natural biomaterials. J Biomed Mater Res 2001; 56: 545-55.
49. Dohmen PM, da Costa F, Yoschi S, Lopes SV, da Souza FP, Konertz W. Can autologous vascular endothelial cell seeding increase the patency rate of small-diameter No-React-treated bovine internal mammary arteries? An in vivo study in juvenile sheep. Med Sci Monit 2007; 13: BR188-93.
50. Douville EC, Kempczinski RF, Birinyi LK, Ramalanjaona GR. Impact of endothelial cell seeding on long-term patency and subendothelial proliferation in a small-caliber highly porous polytetrafluoroethylene graft. J Vasc Surg 1987; 5: 544-50.
51. Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells, Sect. (2004).
52. Ellenby MI, Ernst CB, Carretero OA, Scicli AG. Role of nitric oxide in the effect of blood flow Thromb Haemost 1995; 74: 406-10.
53. Erbs S, Linke A, Adams V, Lenk K, Thiele H, Diederich KW, et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 2005; 97: 756-62.
54. Exton RJ, Galland RB. Major groin complications following the use of synthetic grafts. Eur J Vasc Endovasc Surg 2007; 34: 188-90.
55. Fan CL, Gao PJ, Che ZQ, Liu JJ, Wei J, Zhu DL. Therapeutic neovascularization by autologous transplantation with expanded endothelial progenitor cells from peripheral blood into ischemic hind limbs. Acta Pharmacol Sin 2005; 26: 1069-75.
56. Fang NT, Xie SZ, Wang SM, Gao HY, Wu CG, Pan LF. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Chin Med J (Engl) 2007; 120: 696-702.
57. Fichelle JM, Marzelle J, Colacchio G, Gigou F, Cormier F, Cormier JM. Infrapopliteal polytetrafluoroethylene and composite bypass: factors influencing patency. Ann Vasc Surg 1995; 9: 187-96.
58. Fields RC, Solan A, McDonagh KT, Niklason LE, Lawson JH. Gene therapy in tissue-engineered blood vessels. Tissue Eng 2003; 9: 1281-7.
59. Fischlein T, Fasol R. In vitro endothelialization of bioprosthetic heart valves. J Heart Valve Dis 1996; 5: 58-65.
60. Flugelman MY. Inhibition of intravascular thrombosis and vascular smooth muscle cell proliferation by gene therapy. Thromb Haemost 1995; 74: 406-10.
61. Formichi MJ, Guidoin RG, Jausseran JM, Awad JA, Johnston KW, King MW, et al. Expanded PTFE prostheses as arterial substitutes in humans: late pathological findings in 73 excised grafts. Ann Vasc Surg 1988; 2: 14-27.
62. Friedman SG, Lazzaro RS, Spier LN, Moccio C, Tortolani AJ. A prospective randomized comparison of Dacron and polytetrafluoroethylene aortic bifurcation grafts. Surgery 1995; 117: 7-10.
63. Gabriel M, Pukacki F, Dzieciuchowicz L, Oszkinis G, Checinski P. Cryopreserved arterial allografts in the treatment of prosthetic graft infections. Eur J Vasc Endovasc Surg 2004; 27: 590-6.
64. Gale SS, Shuman S, Beebe HG, Pigott JP, Comerota AJ. Percutaneous venous valve bioprosthesis: initial observations. Vasc Endovascular Surg 2004; 38: 221-4.
65. Galletti PM, Aebischer P, Sasken HF, Goddard MB, Chiu TH. Experience with fully bioresorbable aortic grafts in the dog. Surgery 1988; 103: 231-41.
66. Gansera B, Schiller M, Kiask T, Angelis L, Neumaier-Prauser P, Kemkes BM. Internal thoracic artery vs. vein grafts-postoperative angiographic fi ndings in symptomatic patients after 1000 days. Thorac Cardiovasc Surg 2003; 51: 239-43.
67. Gewebetransplantation, Deutsche Gesellschaft fuer. Jahresbericht 2007 2008; 36.
68. Gibbons CP, Ferguson CJ, Fligelstone LJ, Edwards K. Experience with femoro-popliteal vein as a conduit for vascular reconstruction in infected fi elds. Eur J Vasc Endovasc Surg 2003; 25: 424-31.
69. Giudiceandrea A, Seifalian AM, Krijgsman B, Hamilton G. Effect of prolonged pulsatile shear stress in vitro on endothelial cell seeded PTFE and compliant polyurethane vascular grafts. Eur J Vasc Endovasc Surg 1998; 15: 147-54.
70. Gomez-Jorge J, Venbrux AC, Magee C. Percutaneous deployment of a valved bovine jugular vein in the swine venous system: a potential treatment for venous insuffi ciency. J Vasc Interv Radiol 2000; 11: 931-6.
71. Gong Z, Niklason LE. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 2008; 22: 1635-48.
72. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004; 25: 5681-703.
73. Goyanes J. Nuevos trabajos de chirurgia vascular substitucion plastica de las venas e arterioplastica venosa, aplicada cuno nuevo metodo al tratamiento de los aneurismos. Siglo Med 1906; 53: 543-61.
74. Grigioni M, Daniele C, Gensabella R, D'Avenio G, Barbaro V. The role of usable length in the compliance measurement of vascular prostheses. Int J Artif Organs 1999; 22: 837-42.
75. Gu YQ, Zhang J, Guo LR, Qi LX, Zhang SW, Xu J, et al. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia. Chin Med J (Engl) 2008; 121: 963-7.
76. Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG, et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003; 93: 1023-5.
77. Hallin RW, Sweetman WR. The Sparks' mandril graft. A seven year follow-up of mandril grafts placed by Charles H. Sparks and his associates. Am J Surg 1976; 132: 221-3.
78. Harding SI, Afoke A, Brown RA, MacLeod A, Shamlou PA, Dunnill P. Engineering and cell attachment properties of human fi bronectin-fibrinogen scaffolds for use in tissue engineered blood vessels. Bioprocess Biosyst Eng 2002; 25: 53-9.
79. Hashi CK, Zhu Y, Yang GY, Young WL, Hsiao BS, Wang K, et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofi brous vascular grafts. Proc Natl Acad Sci U S A 2007; 104: 11915-20.
80. He H, Shirota T, Yasui H, Matsuda T. Canine endothelial progenitor cell-lined hybrid vascular graft with nonthrombogenic potential. J Thorac Cardiovasc Surg 2003; 126: 455-64.
81. Hendrikx M, Hensen K, Clijsters C, Jongen H, Koninckx H, Bijnens E, et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006; 114: I101-7.
82. Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery 1978; 84: 498-504.
83. Herring M, Smith J, Dalsing M, Glover J, Compton R, Etchberger K, et al. Endothelial seeding of polytetrafluoroethylene femoral popliteal bypasses: the failure of low-density seeding to improve patency. J Vasc Surg 1994; 20: 650-5.
84. Herring MB, LeGrand DR. The histology of seeded PTFE grafts in humans. Ann Vasc Surg 1989; 3: 96-103.
85. Hoerstrup SP, Zund G, Sodian R, Schnell AM, Grunenfelder J, Turina MI. Tissue engineering of small caliber vascular grafts. Eur J Cardiothorac Surg 2001; 20: 164-9.
86. Hoffmann J, Paul A, Harwardt M, Groll J, Reeswinkel T, Klee D, et al. Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J Biomed Mater Res A 2008; 84: 614-21.
87. Holdsworth RJ, Naidu S, Gervaz P, McCollum PT. Glutaraldehyde-tanned bovine carotid artery graft for infrainguinal vascular reconstruction: 5-year follow-up. Eur J Vasc Endovasc Surg 1997; 14: 208-11.
88. Honduvilla NG, Bujan J, Lizarbe MA, Bellon JM, Olmo N, Hernando A. Adhesion, stability of fi bronectin on PTFE before, after seeding with normal and synchronized endothelial cells: in vitro study. Artif Organs 1995; 19: 144-53.
89. Huang PP, Yang XF, Li SZ, Wen JC, Zhang Y, Han ZC. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost 2007; 98: 1335-42.
90. Ishii Y, Sakamoto S, Kronengold RT, Virmani R, Rivera EA, Goldman SM, et al. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency. J Tho rac Cardiovasc Surg 2008; 135: 1237-45; discussion 45-6.
91. James NL, Schindhelm K, Slowiaczek P, Milthorpe BK, Dudman NP, Johnson G, et al. Endothelial cell seeding of small diameter vascular grafts. Artif Organs 1990; 14: 355-60.
92. Jang JH, Houchin TL, Shea LD. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices 2004; 1: 127-38.
93. Jarrell BE, Williams SK, Rose D, Garibaldi D, Talbot C, Kapelan B. Optimization of human endothelial cell attachment to vascular graft polymers. J Biomech Eng 1991; 113: 120-2.
94. Jeger E. Die Chirurgie der Blutgefäße und des Herzens. Berlin. Hirschwald: 1913.
95. Jensen LP, Lepantalo M, Fossdal JE, Roder OC, Jensen BS, Madsen MS, et al. Dacron or PTFE for above-knee femoropopliteal bypass. a multicenter randomised study. Eur J Vasc Endovasc Surg 2007; 34: 44-9.
96. Jevon M, Dorling A, Hornick PI. Progenitor cells and vascular disease. Cell Prolif 2008; 41 Suppl 1: 146-64.
97. Jockenhoevel S, Zund G, Hoerstrup SP, Chalabi K, Sachweh JS, Demircan L, et al. Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2001; 19: 424-30.
98. Kadletz M, Magometschnigg H, Minar E, Konig G, Grabenwoger M, Grimm M, et al. Implantation of in vitro endothelialized polytetrafluoroethylene grafts in human beings. A preliminary report. J Thorac Cardiovasc Surg 1992; 104: 736-42.
99. Kadletz M, Moser R, Preiss P, Deutsch M, Zilla P, Fasol R. In vitro lining of fi bronectin coated PTFE grafts with cryo-preserved saphenous vein endothelial cells. Thorac Cardiovasc Surg 1987; 35 Spec No 2: 143-7.
100. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422-7.
101. Kallenbach K, Leyh RG, Lefik E, Walles T, Wilhelmi M, Cebotari S, et al. Guided tissue regeneration: porcine matrix does not transmit PERV. Biomaterials 2004; 25: 3613-20.
102. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7: 1035-40.
103. Kawamoto A, Asahara T, Losordo DW. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med 2002; 3: 221-5.
104. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003; 107: 461-8.
105. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 2001; 12: 383-9.
106. Kirma C, Akcakoyun M, Esen AM, Barutcu I, Karakaya O, Saglam M, et al. Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. Circ J 2007; 71: 698-702
107. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for aboveknee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004; 27: 357-62.
108. Koller MR, Papoutsakis ET. Cell adhesion in animal cell culture: physiological and fluid-mechanical implications. Bioprocess Technol 1995; 20: 61-110.
109. Kretschmer G, Polterauer P, Wagner O, Piza F. [Sparks grafts as arterial substitutes in the femoro-popliteal region with a postoperative follow-up of up to 54 months]. Helv Chir Acta 1981; 48: 243-50.
110. Kudo FA, Nishibe T, Nishibe M, Yasuda K. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int Angiol 2003; 22: 344-8.
111. Kunlin J. Le traitement l'arterite obliterante par la greffe veneuse. Arch Mal Coeur 1949; 42: 371.
112. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12: 361-5.
113. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J 1998; 12: 47-56.
114. Lalka SG, Oelker LM, Malone JM, Duhamel RC, Kevorkian MA, Raper BA, et al. Acellular vascular matrix: a natural endothelial cell substrate. Ann Vasc Surg 1989; 3: 108-17.
115. Lantz GC, Badylak SF, Hiles MC, Coffey AC, Geddes LA, Kokini K, et al. Small intestinal submucosa as a vascular graft: a review. J Invest Surg 1993; 6: 297-310.
116. Laube HR, Duwe J, Rutsch W, Konertz W. Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. J Thorac Cardiovasc Surg 2000; 120: 134-41.
117. Lehalle B, Geschier C, Fieve G, Stoltz JF. Early rupture and degeneration of cryopreserved arterial allografts. J Vasc Surg 1997; 25: 751-2.
118. Lehle K, Buttstaedt J, Birnbaum DE. Expression of adhesion molecules and cytokines in vitro by endothelial cells seeded on various polymer surfaces coated with titaniumcarboxonitride. J Biomed Mater Res A 2003; 65: 393-401.
119. Lenk K, Adams V, Lurz P, Erbs S, Linke A, Gielen S, et al. Therapeutical potential of bloodderived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur Heart J 2005; 26: 1903-9.
120. Leseche G, Ohan J, Bouttier S, Palombi T, Bertrand P, Andreassian B. Above-knee femoropopliteal bypass grafting using endothelial cell seeded PTFE grafts: five-year clinical experience. Ann Vasc Surg 1995; 9 Suppl: S15-23.
121. Leung BM, Sefton MV. A modular tissue engineering construct containing smooth muscle cells and endothelial cells. Ann Biomed Eng 2007; 35: 2039-49.
122. Leuprecht A, Perktold K, Prosi M, Berk T, Trubel W, Schima H. Numerical study of hemodynamics and wall mechanics in distal end-to-side anastomoses of bypass grafts. J Biomech 2002; 35: 225-36.
123. Lexer E. Die ideale Operation des arteriellen und arteriovenösen Aneurysmas. Arch Klin Chir 1907; 83: 459-63.
124. Licht P, Jacobsen E, Lerbjerg G, Andersen PE, Alstrup P. Cephalic veins in coronary artery bypass surgery. Eur J Cardiothorac Surg 1996; 10: 327-30.
125. Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007; 115: 3165-72.
126. Luscher TF, Barton M. Biology of the endothelium. Clin Cardiol 1997; 20: II-3-10.
127. Lv Q, Hu K, Feng Q, Cui F. Fibroin/collagen hybrid hydrogels with crosslinking method: preparation, properties, and cytocompatibility. J Biomed Mater Res A 2008; 84: 198-207.
128. Magee TR, Niblett PG, Campbell WB. Reinforced vascular grafts: a comparative study. Eur J Vasc Surg 1992; 6: 21-5.
129. Magre S, Takeuchi Y, Bartosch B. Xenotransplantation and pig endogenous retroviruses. Rev Med Virol 2003; 13: 311-29.
130. Malone JM, Brendel K, Duhamel RC, Reinert RL. Detergent-extracted small-diameter vascular prostheses. J Vasc Surg 1984; 1: 181-91.
131. Mantero S, Pietrabissa R, Motta A, Ferrari M, Berchiolli R. A new pericardium vascular prosthesis: mechanical behavior SEM analyses and clinical indications. Int J Artif Organs 1996; 19: 372-8.
132. Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin'oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 2003; 24: 2303-8.
133. McFetridge PS, Daniel JW, Bodamyali T, Horrocks M, Chaudhuri JB. Preparation of porcine carotid arteries for vascular tissue engineering applications. J Biomed Mater Res A 2004; 70: 224-34.
134. McLean J. The discovery of heparin. Circulation 1959; 19: 75-8.
135. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 2001; 71: S327-31.
136. Merzkirch C, Davies N, Zilla P. Engineering of vascular ingrowth matrices: are protein domains an alternative to peptides? Anat Rec 2001; 263: 379-87.
137. Miyamoto M, Yasutake M, Takano H, Takagi H, Takagi G, Mizuno H, et al. Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Cell Transplant 2004; 13: 429-37.
138. Miyata T, Conte MS, Trudell LA, Mason D, Whittemore AD, Birinyi LK. Delayed exposure to pulsatile shear stress improves retention of human saphenous vein endothelial cells on seeded ePTFE grafts. J Surg Res 1991; 50: 485-93.
139. Miyauchi M, Shionoya S. Complement activation by vascular prostheses and its role in progression of arteriosclerotic lesions. Angiology 1988; 39: 881-90.
140. Moonen JR, de Leeuw K, van Seijen XJ, Kallenberg CG, van Luyn MJ, Bijl M, et al. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther 2007; 9: R84.
141. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, et al. Transplanted cord bloodderived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-36.
142. Murray GD, Best CH. The Use of Heparin in Thrombosis. Ann Surg 1938; 108: 163-77.
143. Nauck M, Roth M, Tamm M, Eickelberg O, Wieland H, Stulz P, et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol 1997; 16: 398-406.
144. Nehls V, Herrmann R. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc Res 1996; 51: 347-64.
145. Nehls V, Schuchardt E and Drenckhahn D. The effect of fi broblasts, vascular smooth muscle cells, and pericytes on sprout formation of endothelial cells in a fibrin gel angiogenesis system. Microvasc Res 1994; 48: 349-63.
146. Nemcova S, Noel AA, Jost CJ, Gloviczki P, Miller VM and Brockbank KG. Evaluation of a xenogeneic acellular collagen matrix as a small-diameter vascular graft in dogs-preliminary observations. J Invest Surg 2001; 14: 321-30.
147. Neufang A, Espinola-Klein C, Dorweiler B, Messow CM, Schmiedt W and Vahl CF. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV). J Vasc Surg 2007; 46: 280-8.
148. Neufang A, Espinola-Klein C, Dorweiler B, Savvidis S, Schmiedt W and Vahl CF. Infrapopliteal composite bypass with autologous vein and second generation glutaraldehyde stabilized human umbilical vein (HUV) for critical lower limb ischaemia. Eur J Vasc Endovasc Surg 2007; 34: 583-9.
149. Nevelsteen A, Feryn T, Lacroix H, Suy R and Goffin Y. Experience with cryopreserved arterial allografts in the treatment of prosthetic graft infections. Cardiovasc Surg 1998; 6: 378-83.
150. Niklason LE. Techview: medical technology. Replacement arteries made to order. Science 1999; 286: 1493-4.
151. Niklason LE, Abbott W, Gao J, Klagges B, Hirschi KK, Ulubayram K, et al. Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg 2001; 33: 628-38.
152. Nikolaychik VV, Samet MM and Lelkes PI. A new, cryoprecipitate based coating for improved endothelial cell attachment and growth on medical grade artificial surfaces. ASAIO J 1994; 40: M846-52.
153. Ofenloch JC, Chen C, Hughes JD and Lumsden AB. Endoscopic venous valve transplantation with a valve-stent device. Ann Vasc Surg 1997; 11: 62-7.
154. Panetta TF, Marin ML, Veith FJ, Goldsmith J, Gordon RE, Jones AM, et al. Unsuspected preexisting saphenous vein disease: an unrecognized cause of vein bypass failure. J Vasc Surg 1992; 15: 102-10; discussion 10-2.
155. Panneton JM, Hollier LH and Hofer JM. Multicenter randomized prospective trial comparing a pre-cuffed polytetrafluoroethylene graft to a vein cuffed polytetrafluoroethylene graft for infragenicular arterial bypass. Ann Vasc Surg 2004; 18: 199-206.
156. Pavcnik D, Machan L, Uchida B, Kaufman J, Keller FS and Rosch J. Percutaneous prosthetic venous valves: current state and possible applications. Tech Vasc Interv Radiol 2003; 6: 137-42.
157. Pavcnik D, Uchida B, Kaufman J, Hinds M, Keller FS and Rosch J. Percutaneous management of chronic deep venous reflux: review of experimental work and early clinical experience with bioprosthetic valve. Vasc Med 2008; 13: 75-84.
158. Pavcnik D, Yin Q, Uchida B, Park WK, Hoppe H, Kim MD, et al. Percutaneous autologous venous valve transplantation: short-term feasibility study in an ovine model. J Vasc Surg 2007; 46: 338-45.
159. Perea H, Aigner J, Heverhagen JT, Hopfner U and Wintermantel E. Vascular tissue engineering with magnetic nanoparticles: seeing deeper. J Tissue Eng Regen Med 2007; 1: 318-21.
160. Perktold K, Leuprecht A, Prosi M, Berk T, Czerny M, Trubel W, et al. Fluid dynamics, wall mechanics, and oxygen transfer in peripheral bypass anastomoses. Ann Biomed Eng 2002; 30: 447-60.
161. Post S, Kraus T, Muller-Reinartz U, Weiss C, Kortmann H, Quentmeier A, et al. Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg 2001; 22: 226-31.
162. Prasad Chennazhy K and Krishnan LK. Effect of passage number and matrix characteristics on differentiation of endothelial cells cultured for tissue engineering. Biomaterials 2005; 26: 5658-67.
163. Prasad CK and Krishnan LK. Regulation of endothelial cell phenotype by biomimetic matrix coated on biomaterials for cardiovascular tissue engineering. Acta Biomater 2008; 4: 182-91.
164. Preis M, Cohen T, Sarnatzki Y, Ben Yosef Y, Schneiderman J, Gluzman Z, et al. Effects of fibulin-5 on attachment, adhesion, and proliferation of primary human endothelial cells. Biochem Biophys Res Commun 2006; 348: 1024-33.
165. Rafii S and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-12.
166. Richardson TP, Peters MC, Ennett AB and Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001; 19: 1029-34.
167. Risteski PS, Akbulut B, Moritz A and Aybek T. The radial artery as a conduit for coronary artery bypass grafting: review of current knowledge. Anadolu Kardiyol Derg 2006; 6: 153-62.
168. Roh JD, Brennan MP, Lopez-Soler RI, Fong PM, Goyal A, Dardik A, et al. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques. J Pediatr Surg 2007; 42: 198-202.
169. Rokosny S, Kiss J, Wohlfahrt P, Balaz P, Matia I, Stefan T, et al. [Experimental use of the peritoneal graft as a vascular prosthesis]. Rozhl Chir 2005; 84: 228-32.
170. Rosenberg N, Martinez A, Sawyer PN, Wesolowski SA, Postlethwait RW and Dillon ML, Jr. Tanned collagen arterial prosthesis of bovine carotid origin in man. Preliminary studies of enzyme-treated heterografts. Ann Surg 1966; 164: 247-56.
171. Rosenman JE, Pearce WH and Kempczinski RF. Bacterial adherence to vascular grafts after in vitro bacteremia. J Surg Res 1985; 38: 648-55.
172. Sales VL, Engelmayr GC, Jr., Mettler BA, Johnson JA, Jr., Sacks MS and Mayer JE, Jr. Transforming growth factorbeta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds. Circulation 2006; 114: I193-9.
173. Sandmann W and Kremer K. [Material problems in vascular surgery]. Chirurg 1983; 54: 433-43.
174. Sarac TP, Carnevale K, Smedira N, Tanquilut E, Augustinos P, Patel A, et al. In vivo and mechanical properties of peritoneum/fascia as a novel arterial substitute. J Vasc Surg 2005; 41: 490-7.
175. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004; 44: 1690-9.
176. Schaefer A, Meyer GP, Fuchs M, Klein G, Kaplan M, Wollert KC, et al. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J 2006; 27: 929-35.
177. Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, Leichter RF, et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 2004; 40: 146-53.
178. Scharn DM, Dirven M, Barendregt WB, Boll AP, Roelofs D and van der Vliet JA. Human umbilical vein versus heparinbonded polyester for femoropopliteal bypass: 5-year results of a prospective randomized multicentre trial. Eur J Vasc Endovasc Surg 2008; 35: 61-7.
179. Schmidt CE and Baier JM. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000; 21: 2215-31.
180. Schmidt D, Asmis LM, Odermatt B, Kelm J, Breymann C, Gossi M, et al. Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors. Ann Thorac Surg 2006; 82: 1465-71; discussion 71.
181. Seifalian AM, Salacinski HJ, Tiwari A, Edwards A, Bowald S and Hamilton G. In vivo biostability of a poly(carbonateurea) urethane graft. Biomaterials 2003; 24: 2549-57.
182. Serrano MC, Pagani R, Ameer GA, Vallet-Regi M and Portoles MT. Endothelial cells derived from circulating progenitors as an effective source to functional endothelialization of NaOH-treated poly(epsiloncaprolactone) films. J Biomed Mater Res A 2008;
183. Shen G, Tsung HC, Wu CF, Liu XY, Wang XY, Liu W, et al. Tissue engineering of blood vessels with endothelial cells differentiated from mouse embryonic stem cells. Cell Res 2003; 13: 335-41.
184. Shepard AD, Gelfand JA, Callow AD and O'Donnell TF, Jr. Complement activation by synthetic vascular prostheses. J Vasc Surg 1984; 1: 829-38.
185. Shichiri M, Fukai N, Ozawa N, Iwasaki H and Hirata Y. Adrenomedullin is an autocrine/paracrine growth factor for rat vascular smooth muscle cells. Regul Pept 2003; 112: 167-73.
186. Shin'oka T, Imai Y and Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001; 344: 532-3.
187. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005; 129: 1330-8.
188. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, et al. Tissue engineering heart valves: valve leafl et replacement study in a lamb model. Ann Thorac Surg 1995; 60: S513-6.
189. Shirota T, He H, Yasui H and Matsuda T. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng 2003; 9: 127-36.
190. Simper D, Stalboerger PG, Panetta CJ, Wang S and Caplice NM. Smooth muscle progenitor cells in human blood. Circulation 2002; 106: 1199-204.
191. Sottiurai VS. Biogenesis and etiology of distal anastomotic intimal hyperplasia. Int Angiol 1990; 9: 59-69.
192. Sottiurai VS. Distal Anastomotic Intimal Hyperplasia: Histocytomorphology, Pathophysiology, Etiology, and Prevention. Int J Angiol 1999; 8: 1-10.
193. Sparks CH. Silicone mandril method for growing reinforced autogenous femoro-popliteal artery grafts in situ. Ann Surg 1973; 177: 293-300.
194. Sreerekha PR, Divya P and Krishnan LK. Adult stem cell homing and differentiation in vitro on composite fibrin matrix. Cell Prolif 2006; 39: 301-12.
195. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 2000; 102: III50-5.
196. Sung HJ, Meredith C, Johnson C and Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004; 25: 5735-42.
197. Tada S and Tarbell JM. Flow through internal elastic lamina affects shear stress on smooth muscle cells (3D simulations). Am J Physiol Heart Circ Physiol 2002; 282: H576-84.
198. Tai NR, Giudiceandrea A, Salacinski HJ, Seifalian AM and Hamilton G. In vivo femoropopliteal arterial wall compliance in subjects with and without lower limb vascular disease. J Vasc Surg 1999; 30: 936-45.
199. Tai NR, Salacinski HJ, Edwards A, Hamilton G and Seifalian AM. Compliance properties of conduits used in vascular reconstruction. Br J Surg 2000; 87: 1516-24.
200. Tamura N, Nakamura T, Terai H, Iwakura A, Nomura S, Shimizu Y, et al. A new acellular vascular prosthesis as a scaffold for host tissue regeneration. Int J Artif Organs 2003; 26: 783-92.
201. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bonemarrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-35.
202. Teebken OE and Haverich A. Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg 2002; 23: 475-85.
203. Teebken OE, Pichlmaier AM and Haverich A. Cell seeded decellularised allogeneic matrix grafts and biodegradable polydioxanone-prostheses compared with arterial autografts in a porcine model. Eur J Vasc Endovasc Surg 2001; 22: 139-45.
204. Teebken OE, Pichlmaier MA, Brand S and Haverich A. Cryopreserved arterial allografts for in situ reconstruction of infected arterial vessels. Eur J Vasc Endovasc Surg 2004; 27: 597-602.
205. Teebken OE, Puschmann C, Aper T, Haverich A and Mertsching H. Tissue-engineered bioprosthetic venous valve: a long-term study in sheep. Eur J Vasc Endovasc Surg 2003; 25: 305-12.
206. Teng ZZ, Ji GY, Chu HJ, Li ZY, Zou LJ, Xu ZY, et al. Does PGA external stenting reduce compliance mismatch in venous grafts? Biomed Eng Online 2007; 6: 12.
207. Tiwari A, Salacinski HJ, Hamilton G and Seifalian AM. Tissue engineering of vascular bypass grafts: role of endothelial cell extraction. Eur J Vasc Endovasc Surg 2001; 21: 193-201.
208. Tousoulis D, Charakida M and Stefanadis C. Endothelial function and inflammation in coronary artery disease. Heart 2006; 92: 441-4.
209. Trubel W, Schima H, Moritz A, Raderer F, Windisch A, Ullrich R, et al. Compliance mismatch and formation of distal anastomotic intimal hyperplasia in externally stiffened and lumenadapted venous grafts. Eur J Vasc Enodovasc Surg 1995; 10: 415-23
210. Tu JV, Pashos CL, Naylor CD, Chen E, Normand SL, Newhouse JP, et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997; 336: 1500-5.
211. Ucuzian AA and Greisler HP. In vitro models of angiogenesis. World J Surg 2007; 31: 654-63.
212. van Wachem PB, Stronck JW, Koers-Zuideveld R, Dijk F and Wildevuur CR. Vacuum cell seeding: a new method for the fast application of an evenly distributed cell layer on porous vascular grafts. Biomaterials 1990; 11: 602-6.
213. Vanhoutte PM. Vascular physiology: the end of the quest? Nature 1987; 327: 459-60.
214. Vogt PR, Brunner-La Rocca HP, Carrel T, von Segesser LK, Ruef C, Debatin J, et al. Cryopreserved arterial allografts in the treatment of major vascular infection: a comparison with conventional surgical techniques. J Thorac Cardiovasc Surg 1998; 116: 965-72.
215. Vogt PR, Stallmach T, Niederhauser U, Schneider J, Zund G, Lachat M, et al. Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. Eur J Cardiothorac Surg 1999; 15: 639-44; discussion 44-5.
216. Voorhees AB, Jr., Jaretzki A, 3rd and Blakemore AH. The use of tubes constructed from vinyon "N" cloth in bridging arterial defects. Ann Surg 1952; 135: 332-6.
217. Walluscheck KP, Steinhoff G, Kelm S and Haverich A. Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGDcontaining peptides. Eur J Vasc Endovasc Surg 1996; 12: 321-30.
218. Wang EY, Giclas PC, Tu RH, Hata C and Quijano RC. A comparative study of complement activation by Denaflex, Bioflow, and BioPolyMeric vascular grafts. ASAIO J 1993; 39: M691-4.
219. Wang Z, Wang S, Marois Y, Guidoin R and Zhang Z. Evaluation of biodegradable synthetic scaffold coated on arterial prostheses implanted in rat subcutaneous tissue. Biomaterials 2005; 26: 7387-401.
220. Weinberg CB and Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986; 231: 397-400.
221. White RA. The effect of porosity and biomaterial on the healing and long-term mechanical properties of vascular prostheses. ASAIO Trans 1988; 34: 95-100.
222. Williams C and Wick TM. Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Eng 2004; 10: 930-41.
223. Williams SK and Jarrell BE. Tissue-engineered vascular grafts. Nat Med 1996; 2: 32-4.
224. Williamson MR, Shuttleworth A, Canfi eld AE, Black RA and Kielty CM. The role of endothelial cell attachment to elastic fibre molecules in the enhancement of monolayer formation and retention, and the inhibition of smooth muscle cell recruitment. Biomaterials 2007; 28: 5307-18.
225. Wilson GJ, Courtman DW, Klement P, Lee JM and Yeger H. Acellular matrix: a biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg 1995; 60: S353-8.
226. Yamamoto K, Kondo T, Suzuki S, Izawa H, Kobayashi M, Emi N, et al. Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler Thromb Vasc Biol 2004; 24: e192-6.
227. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408: 92-6.
228. Yamauchi F, Okada M, Kato K, Jakt LM and Iwata H. Array-based functional screening for genes that regulate vascular endothelial differentiation of Flk1-positive progenitors derived from embryonic stem cells. Biochim Biophys Acta 2007; 1770: 1085-97.
229. Ye Q, Zund G, Benedikt P, Jockenhoevel S, Hoerstrup SP, Sakyama S, et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2000; 17: 587-91.
230. Yoshida H, Nakamura M, Makita S and Hiramori K. Paracrine effect of human vascular endothelial cells on human vascular smooth muscle cell proliferation: transmembrane co-culture method. Heart Vessels 1996; 11: 229-33.
231. Young RM, Cherry KJ, Jr., Davis PM, Gloviczki P, Bower TC, Panneton JM, et al. The results of in situ prosthetic replacement for infected aortic grafts. Am J Surg 1999; 178: 136-40.
232. Yu H, Dai W, Yang Z, Kirkman P, Weaver FA, Eton D, et al. Smooth muscle cells improve endothelial cell retention on polytetrafluoroethylene grafts in vivo. J Vasc Surg 2003; 38: 557-63.
233. Zhang H, Zhang N, Li M, Feng H, Jin W, Zhao H, et al. Therapeutic Angiogenesis of Bone Marrow Mononuclear Cells (MNCs) and Peripheral Blood MNCs: Transplantation for Ischemic Hindlimb. Ann Vasc Surg 2008; 22: 238-47.
234. Zhang J, Qi H, Wang H, Hu P, Ou L, Guo S, et al. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft. Artif Organs 2006; 30: 898-905.
235. Zhang L, Yang R and Han ZC. Transplantation of umbilical cord blood-derived endothelial progenitor cells: a promising method of therapeutic revascularisation. Eur J Haematol 2006; 76: 1-8.
236. Zhou B, Ma FX, Liu PX, Fang ZH, Wang SL, Han ZB, et al. Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells. J Lipid Res 2007; 48: 518-27.
237. Zhou W, Lin PH, Bush RL, Terramani TT, Matsuura JH, Cox M, et al. In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections: a multi-institutional experience. Tex Heart Inst J 2006; 33: 14-8.